Evidence map›Paper›PMID 32671946›Full record

ArticlePhysiological reports2020

Mapping of the FGF14:Nav1.6 complex interface reveals FLPK as a functionally active peptide modulating excitability.

Aditya K Singh, Paul A Wadsworth, Cynthia M Tapia, Giuseppe Aceto, Syed R Ali, Haiying Chen, Marcello D'Ascenzo, Jia Zhou, Fernanda Laezza

Abstract read
In one paragraph

Article in Physiological reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Voltage-Gated NaLife (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Differential Modulation of the Voltage-Gated NaFrontiers in molecular biosciences · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aditya K SinghDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0001-7549-8163
Paul A WadsworthDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0002-4562-7830
Cynthia M TapiaDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
Giuseppe AcetoDepartment of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Syed R AliDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0001-7802-4713
Haiying ChenDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
Marcello D'AscenzoDepartment of Neuroscience, Università Cattolica del Sacro Cuore, Rome, Italy.
Jia ZhouDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0002-2811-1090
Fernanda LaezzaDepartment of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0003-1141-1852

Funding

Molecular Mechanisms of Environmental InjuryT32ES007254 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI AMEREDES, BILL T · 1990 to 2022
$6.6M
Validation of FGF14 as a New Molecular Target of GSK3R01MH095995 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2012 to 2016
$1.9M
Discovery of Chemical Probes for Psychiatric Disorders and AddictionR01MH111107 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA, ZHOU, JIA · 2016 to 2018
$1.6M
Training in Pharmacological SciencesT32GM089657 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HANCOCK, JOHN F · 2010 to 2014
$728k
Clinical and Behavioral Science Training in Aging and Health DisparitiesT32AG051131 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MARKIDES, KYRIAKOS S · 2015 to 2019
$436k
Malvern MicroCal PEAQ Isothermal Titration CalorimeterS10OD023576 · OD · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJARATHNAM, KRISHNA · 2017 to 2017
$120k
NIA NIH HHS T32 AG051131NIEHS NIH HHS T32 ES007254NIGMS NIH HHS T32 GM089657NIH HHS R01-MH095995NIH HHS R01-MH111107NIH HHS S10 OD023576NIH HHS T32-ES007254NIMH NIH HHS R01 MH095995NIMH NIH HHS R01 MH111107NIMH NIH HHS T32-AG051131NIMH NIH HHS T32-GM089657
6 · The paper itself

Abstract

The voltage-gated sodium (Nav) channel complex is comprised of pore-forming α subunits (Nav1.1-1.9) and accessory regulatory proteins such as the intracellular fibroblast growth factor 14 (FGF14). The cytosolic Nav1.6 C-terminal tail binds directly to FGF14 and this interaction modifies Nav1.6-mediated currents with effects on intrinsic excitability in the brain. Previous studies have identified the FGF14

Indexed as

AnimalsFibroblast Growth FactorsHEK293 CellsHumansMiceMice, Inbred C57BLMolecular Docking SimulationNAV1.6 Voltage-Gated Sodium ChannelNeuronsPeptide FragmentsProtein BindingProtein Interaction MapsRecombinant Fusion Proteinsfibroblast growth factor 14Fibroblast Growth FactorsNAV1.6 Voltage-Gated Sodium ChannelPeptide FragmentsRecombinant Fusion ProteinsSCN8A protein, humanaccessory proteinexcitabilityinactivationsodium channels

Identifiers

PMID32671946
PMCPMC7363588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.